Cargando…

Supporting pregnant women not ready to quit smoking: an economic evaluation

OBJECTIVES: Some pregnant women are not ready or do not want to quit smoking completely, and currently there is no support provided for these women in the UK. Offering help to reduce smoking could reduce the health risks associated with smoking and increase the limited reach of the NHS Stop Smoking...

Descripción completa

Detalles Bibliográficos
Autores principales: Avşar, Tuba Saygın, Jackson, Louise, Barton, Pelham, Jones, Matthew, McLeod, Hugh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686103/
https://www.ncbi.nlm.nih.gov/pubmed/36419041
http://dx.doi.org/10.1186/s12884-022-05150-8
_version_ 1784835665982128128
author Avşar, Tuba Saygın
Jackson, Louise
Barton, Pelham
Jones, Matthew
McLeod, Hugh
author_facet Avşar, Tuba Saygın
Jackson, Louise
Barton, Pelham
Jones, Matthew
McLeod, Hugh
author_sort Avşar, Tuba Saygın
collection PubMed
description OBJECTIVES: Some pregnant women are not ready or do not want to quit smoking completely, and currently there is no support provided for these women in the UK. Offering help to reduce smoking could reduce the health risks associated with smoking and increase the limited reach of the NHS Stop Smoking Services (SSS) for pregnant women. This study aimed to design and evaluate a hypothetical intervention aimed at pregnant women who are not yet ready or do not want to quit smoking entirely. METHODS: A hypothetical intervention, the Reduced Smoking During Pregnancy (RSDP) intervention, was conceptualised based on the best available evidence. The intervention was evaluated, using a decision-analytic model developed for SDP interventions. Two different scenarios, a base-case and a cautious-case were developed, and a cost-utility analysis and return on investment analysis were conducted. The uncertainty around the estimates was assessed, using deterministic and probabilistic sensitivity analyses. RESULTS: The RSDP intervention could prevent the loss of 13 foetuses and generate 43 quitters 1 year after delivery per 1000 women. In the lifetime analysis, the intervention was cost-effective in both scenarios, with an incremental cost of £363 (95% CI £29 to £672) and 0.44 (95% CI 0.32 to 0.53) QALYs gained in the base-case. CONCLUSIONS: The study found that the hypothetical reduction intervention would produce significant health benefits, reduce smoking and be cost-effective. Offering pregnant smokers help to reduce smoking could reduce health inequalities, widen the reach of SSS and improve health. This economic evaluation of a novel, intensive intervention could inform the piloting of such interventions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12884-022-05150-8.
format Online
Article
Text
id pubmed-9686103
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96861032022-11-25 Supporting pregnant women not ready to quit smoking: an economic evaluation Avşar, Tuba Saygın Jackson, Louise Barton, Pelham Jones, Matthew McLeod, Hugh BMC Pregnancy Childbirth Research OBJECTIVES: Some pregnant women are not ready or do not want to quit smoking completely, and currently there is no support provided for these women in the UK. Offering help to reduce smoking could reduce the health risks associated with smoking and increase the limited reach of the NHS Stop Smoking Services (SSS) for pregnant women. This study aimed to design and evaluate a hypothetical intervention aimed at pregnant women who are not yet ready or do not want to quit smoking entirely. METHODS: A hypothetical intervention, the Reduced Smoking During Pregnancy (RSDP) intervention, was conceptualised based on the best available evidence. The intervention was evaluated, using a decision-analytic model developed for SDP interventions. Two different scenarios, a base-case and a cautious-case were developed, and a cost-utility analysis and return on investment analysis were conducted. The uncertainty around the estimates was assessed, using deterministic and probabilistic sensitivity analyses. RESULTS: The RSDP intervention could prevent the loss of 13 foetuses and generate 43 quitters 1 year after delivery per 1000 women. In the lifetime analysis, the intervention was cost-effective in both scenarios, with an incremental cost of £363 (95% CI £29 to £672) and 0.44 (95% CI 0.32 to 0.53) QALYs gained in the base-case. CONCLUSIONS: The study found that the hypothetical reduction intervention would produce significant health benefits, reduce smoking and be cost-effective. Offering pregnant smokers help to reduce smoking could reduce health inequalities, widen the reach of SSS and improve health. This economic evaluation of a novel, intensive intervention could inform the piloting of such interventions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12884-022-05150-8. BioMed Central 2022-11-23 /pmc/articles/PMC9686103/ /pubmed/36419041 http://dx.doi.org/10.1186/s12884-022-05150-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Avşar, Tuba Saygın
Jackson, Louise
Barton, Pelham
Jones, Matthew
McLeod, Hugh
Supporting pregnant women not ready to quit smoking: an economic evaluation
title Supporting pregnant women not ready to quit smoking: an economic evaluation
title_full Supporting pregnant women not ready to quit smoking: an economic evaluation
title_fullStr Supporting pregnant women not ready to quit smoking: an economic evaluation
title_full_unstemmed Supporting pregnant women not ready to quit smoking: an economic evaluation
title_short Supporting pregnant women not ready to quit smoking: an economic evaluation
title_sort supporting pregnant women not ready to quit smoking: an economic evaluation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686103/
https://www.ncbi.nlm.nih.gov/pubmed/36419041
http://dx.doi.org/10.1186/s12884-022-05150-8
work_keys_str_mv AT avsartubasaygın supportingpregnantwomennotreadytoquitsmokinganeconomicevaluation
AT jacksonlouise supportingpregnantwomennotreadytoquitsmokinganeconomicevaluation
AT bartonpelham supportingpregnantwomennotreadytoquitsmokinganeconomicevaluation
AT jonesmatthew supportingpregnantwomennotreadytoquitsmokinganeconomicevaluation
AT mcleodhugh supportingpregnantwomennotreadytoquitsmokinganeconomicevaluation